Double-blind comparative trial of Nuelin Depot and TheoDur with adjusted dosage in asthmatic adults.
Equivalent doses of two sustained release preparations of theophylline, Nuelin Depot and TheoDur, were compared in a double blind, cross-over study. Twenty adult outpatients with COLD were given adjusted doses of the two preparations to reach a peak value of theophylline in steady state within the therapeutic range. The study consisted of two 14-day periods and airway function parametres, plasma concentrations, asthma symptoms, and side effects were recorded the last day in each period. In addition morning PEFR, use of beta 2 stimulant aerosol and number of nightly attacks were recorded daily. As judged from the peak-trough variation of 24.8 mumol for Nuelin Depot and 26.3 mumol/l for TheoDur as well as the tmax of 4.3 hours for Nuelin and 3.6 hours for TheoDur, both products produced a similar plasma profile. No statistically significant differences were found between the two preparations with respect to airway function parameters, relief of asthma symptoms, need for beta 2-stimulant aerosol or side effects. In conclusion these two sustained release preparations should be considered equivalent for practical use.